1 (Image 1)
Lubiprostone Capsule, Gelatin Coated
Product Images NDC 0480-4138
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 0480-4138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
New (Image 2)
Each soft gel capsule contains 8mcg of Lubiprostone. These capsules are for oral use only and should be swallowed whole without breaking or chewing. The usual dosage should be determined from the package insert. The container should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) and protected from extreme temperatures. The container has a child-resistant closure and should be kept out of the reach of children. Teva Pharmaceuticals manufactures the Lubiprostone Capsules, which should be dispensed in a tight and light-resistant container. The National Drug Code for these capsules is 0480-3479-06. This medicine requires a prescription.*
New (Image 3)
This is a medication called Lubiprostone manufactured by Teva Pharmaceuticals. It comes in a container with 60 capsules, each containing 24 mg of the medication. The dosage instructions are available in the package insert. The container should be kept tightly closed and protected from extreme temperatures. The medication should be swallowed whole and kept out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
